Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Malerba

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Brain Communications|September 21, 2020
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease modelsVeronica Corsetti, Antonella Borreca, Valentina Latina, et al.
Scientific Reports|July 9, 2024
Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patientsSimonetta Lisi, Francesca Malerba, Paola Quaranta, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
A painless nerve growth factor variant uncouples nociceptive and neurotrophic TrkA signalingShailesh Kumar, Harry A Jung, Gerard Walker, et al.
British Journal of Pharmacology|September 10, 2024
A p75 neurotrophin receptor-sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microgliaLaura Latini, Daniel Souza Monteiro De Araujo, Rosario Amato, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Brain Communications|September 21, 2020
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease modelsVeronica Corsetti, Antonella Borreca, Valentina Latina, et al.
Scientific Reports|July 9, 2024
Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patientsSimonetta Lisi, Francesca Malerba, Paola Quaranta, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
A painless nerve growth factor variant uncouples nociceptive and neurotrophic TrkA signalingShailesh Kumar, Harry A Jung, Gerard Walker, et al.
British Journal of Pharmacology|September 10, 2024
A p75 neurotrophin receptor-sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microgliaLaura Latini, Daniel Souza Monteiro De Araujo, Rosario Amato, et al.
Pageof 4